SECOR Capital Advisors, LP - SYNTA PHARMACEUTICALS CORP ownership

SYNTA PHARMACEUTICALS CORP's ticker is SNTA and the CUSIP is 87162T206. A total of 86 filers reported holding SYNTA PHARMACEUTICALS CORP in Q4 2014. The put-call ratio across all filers is 1.76 and the average weighting 1.0%.

Quarter-by-quarter ownership
SECOR Capital Advisors, LP ownership history of SYNTA PHARMACEUTICALS CORP
ValueSharesWeighting
Q3 2015$42,000
-46.2%
23,964
-31.7%
0.01%
-53.6%
Q2 2015$78,000
+14.7%
35,0870.0%0.03%
+3.7%
Q1 2015$68,000
-26.9%
35,0870.0%0.03%
-30.8%
Q4 2014$93,00035,0870.04%
Other shareholders
SYNTA PHARMACEUTICALS CORP shareholders Q4 2014
NameSharesValueWeighting ↓
CAXTON CORP 37,058,136$71,893,00085.78%
ARMISTICE CAPITAL, LLC 3,240,000$6,286,0002.79%
IRONWOOD INVESTMENT MANAGEMENT LLC 738,748$1,433,0000.26%
Geller Advisors LLC 187,323$363,0000.21%
Verity Asset Management, Inc. 56,518$110,0000.11%
STONERIDGE INVESTMENT PARTNERS LLC 334,713$649,0000.08%
Cutler Capital Management, LLC 72,500$140,0000.06%
BLUE ARROW CAPITAL MANAGEMENT LLC 199,930$388,0000.04%
Jefferies Group LLC 3,240,000$6,286,0000.04%
SABBY MANAGEMENT, LLC 399,000$794,0000.03%
View complete list of SYNTA PHARMACEUTICALS CORP shareholders